Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Pfizer and UCSF Will Collaborate
June 16, 2008
| A version of this story appeared in
Volume 86, Issue 24
Pfizer and the University of California, San Francisco, are setting up a wide-ranging research collaboration. Under their three-year, $9.5 million agreement, a university team will identify areas of mutual interest. The plan is to encourage collaborations between Pfizer scientists and the California Institute for Quantitative Biosciences (QB3), headquartered at UCSF, which will oversee the efforts. Pfizer's new Biotherapeutics & Bioinnovation Center, headed by former UC Berkeley professor Corey Goodman, will lead the company's side of the collaboration.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter